SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001649327-17-000001
Filing Date
2017-07-28
Accepted
2017-07-28 13:48:54
Documents
1
Effectiveness Date
2017-07-28
Items
Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 8992
  Complete submission text file 0001649327-17-000001.txt   10325
Mailing Address ONE LETTERMAN DRIVE, BUILDING D SUITE D3-300 SAN FRANCISCO CA 94129
Business Address ONE LETTERMAN DRIVE, BUILDING D SUITE D3-300 SAN FRANCISCO CA 94129 415-989-3639
Redmile Biopharma Investments I, L.P. (Filer) CIK: 0001649327 (see all company filings)

IRS No.: 474587205 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-244604 | Film No.: 17989261